Medexus Pharmaceuticals Inc. (TSX: MDP)

Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	13.07	10.02	18.7	5.23	21.87
Cash & Cash Equivalents	13.07	10.02	18.7	5.23	21.87
Cash Growth	30.46%	-46.44%	257.30%	-76.07%	682.81%
Receivables	22.38	14.41	18.83	14.96	7.44
Inventory	22.85	21.35	14.67	14.09	4.24
Other Current Assets	14.67	3.34	6.37	5.76	1.51
Total Current Assets	72.97	49.11	58.57	40.04	35.06
Property, Plant & Equipment	0.9	1.22	0.8	1.1	0.65
Long-Term Investments	-9.2	0	0	0	-1.16
Goodwill	10.28	10.69	10.65	10.06	6.99
Intangible Assets	70.37	76.57	76.36	69.49	41.79
Other Long-Term Assets	16	1.64	2.13	2.12	1.68
Total Long-Term Assets	88.36	90.11	89.94	82.77	49.95
Total Assets	161.33	139.23	148.51	122.81	85.01
Accounts Payable	10.16	12.05	14.86	8.91	3
Deferred Revenue	27.93	18.38	0	0	0
Current Debt	42.71	15.05	10.57	10.19	0
Other Current Liabilities	2.7	2.64	14.51	15.07	7.59
Total Current Liabilities	83.5	48.11	39.94	34.17	10.59
Long-Term Debt	27.38	39.82	34.3	28.62	16.87
Other Long-Term Liabilities	28.01	33.51	56.26	35.74	29.67
Total Long-Term Liabilities	55.39	73.33	90.56	64.36	46.54
Total Liabilities	138.88	121.43	130.5	98.53	57.14
Total Debt	70.08	54.86	44.87	38.81	16.87
Debt Growth	27.74%	22.26%	15.62%	130.05%	399.05%
Common Stock	69.01	68.69	66.69	42.19	46.39
Retained Earnings	-64.03	-65.25	-62.37	-28.04	-25.27
Comprehensive Income	6.16	3.97	4.2	3.51	1.05
Shareholders' Equity	22.45	17.79	18.02	24.28	27.87
Total Liabilities and Equity	161.33	139.23	148.51	122.81	85.01
Net Cash / Debt	-57.01	-44.84	-26.17	-33.58	5
Net Cash Per Share	-2.78	-2.26	-1.72	-2.34	0.50
Working Capital	-10.53	1	18.63	5.87	24.47
Book Value Per Share	1.12	0.91	1.19	1.69	2.81

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.